latest news releases from the newsroom
Lenetix to Co-Market Combimatrix Molecular Diagnostics' Suite of Developmental Genomics Array-Based Tests
MUKILTEO, Wash., Jan. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), has entered into a new partnership with Lenetix, a New York based laboratory, to co-market CMDX's suite of array CGH based tests including the industry leading BAC HD Scan(tm) test, the most comprehensive test for characterizing genomic causes of childhood developmental disorders. The BAC HD Scan test can identify over 290 genomic causes of developmental disorders and is routinely used in postnatal genetic diagnostics. Also included in CMDX's suite of developmental genomic tests is the Prenatal Scan array CGH test, a more customized test specifically designed and validated for use in prenatal genetic diagnostics. Both companies will launch their co-marketing endeavors at the upcoming Society of Maternal-Fetal Medicine 29th Annual Meeting in San Diego (Jan 26-30th, 2009).
StockerYale, Inc. Implements New Business Development Strategy for Specialty Optical Fiber Unit
SALEM, N.H, and SAN JOSE, Calif., Jan. 26, 2009 (GLOBE NEWSWIRE) -- StockerYale, Inc. (Nasdaq:STKR), a leading designer and manufacturer of structured light lasers, LED modules and specialty optical assemblies for industrial OEMs, medical and defense markets, announced today at the opening of SPIE Photonics West 2009 that its specialty optical fibers (SOF) division is expanding its current business development strategy to further capture market share in key industrial, defense, telecom and medical verticals. The strategy, which leverages SOF's technical expertise, has been solidified with recent business development successes with Boston Scientific Corporation, and with on-going fiber component and fiber laser initiatives with current SOF customers.